Institutional Ownership
Novavax Inc
CUSIP 670002401COM NEWNVAXQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
14.1%
Max % of class reported
Institutional Holders
250
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Feb 11, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 11, 2026 | Bank Of America Corp /De/ | 13G | 5.1% | 8.32M | SEC |
| 2 | Feb 9, 2026 | State Street Corporation | 13G | 5.9% | 9.52M | SEC |
| 3 | Nov 12, 2025 | Shah Capital Management | 13D/A | 8.3% | — | SEC |
| 4 | Oct 14, 2025 | Shah Capital Management | 13D/A | 7.3% | — | SEC |
| 5 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 8.4% | 13.45M | SEC |
| 6 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 9.6% | 15.43M | SEC |
| 7 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 9.6% | 15.43M | SEC |
| 8 | Jul 10, 2024 | State Street Corp | 13G/A | 4.3% | — | SEC |
| 9 | Jun 20, 2024 | Sk Bioscience Co., Ltd. | 13G/A | 4.6% | 6.50M | SEC |
| 10 | May 20, 2024 | Shah Capital Management | 13D/A | 7.8% | 10.97M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Novavax Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Shah Capital Management | 14.85M | $120.84M |
| 2 | Blackrock, Inc. | 12.84M | $104.55M |
| 3 | State Street Corp | 8.97M | $73.02M |
| 4 | D. E. Shaw & Co., Inc. | 7.71M | $62.76M |
| 5 | Sanofi | 6.88M | $56.01M |
| 6 | Bank Of America Corp /De/ | 6.64M | $54.03M |
| 7 | Ubs Group AG | 4.48M | $36.45M |
| 8 | Geode Capital Management, LLC | 3.90M | $31.74M |
| 9 | Millennium Management LLC | 3.85M | $31.36M |
| 10 | Coatue Management LLC | 3.84M | $31.23M |